Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment.
Borrelia burgdorferi infection has been implicated in cutaneous B-cell lymphoma. We report a case of multilesional primary cutaneous large B-cell lymphoma without extracutaneous spread in a patient with elevated B. burgdorferi titers. After antibiotic therapy, clinical remission and a subsequent drop in B. burgdorferi antibody titers were obtained.
Hofbauer
G F
GF
Department of Dermatology, University Hospital, Zürich, Switzerland.
Kessler
B
B
Kempf
W
W
Nestle
F O
FO
Burg
G
G
Dummer
R
R
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D025065:Borrelia burgdorferi / Q000276:immunology; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008193:Lyme Disease / Q000097:blood / Q000276:immunology / Q000517:prevention & control; D016393:Lymphoma, B-Cell / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012878:Skin Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology
D000900:Anti-Bacterial Agents; D004318:Doxycycline